Achilles Therapeutics PLC Financials
| ACHLDelisted Stock | USD 1.48 0.01 0.68% |
Achilles |
Understanding current and past Achilles Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Achilles Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Achilles Therapeutics' assets may result in an increase in income on the income statement.
Achilles Therapeutics Stock Summary
Achilles Therapeutics competes with Assembly Biosciences, Spero Therapeutics, Instil Bio, Nuvation Bio, and CytomX Therapeutics. Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company was founded in 2016 and is headquartered in London, the United Kingdom. Achilles Therapeutics is traded on NASDAQ Exchange in the United States.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US00449L1026 |
| CUSIP | 00449L102 |
| Location | United Kingdom |
| Business Address | 245 Hammersmith Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.achillestx.com |
| Phone | 44 20 8154 4600 |
| Currency | USD - US Dollar |
Achilles Therapeutics Key Financial Ratios
Achilles Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Achilles Therapeutics's current stock value. Our valuation model uses many indicators to compare Achilles Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Achilles Therapeutics competition to find correlations between indicators driving Achilles Therapeutics's intrinsic value. More Info.Achilles Therapeutics PLC is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Achilles Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Achilles Therapeutics PLC Systematic Risk
Achilles Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Achilles Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Achilles Therapeutics PLC correlated with the market. If Beta is less than 0 Achilles Therapeutics generally moves in the opposite direction as compared to the market. If Achilles Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Achilles Therapeutics PLC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Achilles Therapeutics is generally in the same direction as the market. If Beta > 1 Achilles Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Achilles Therapeutics March 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Achilles Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Achilles Therapeutics PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Achilles Therapeutics PLC based on widely used predictive technical indicators. In general, we focus on analyzing Achilles Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Achilles Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.43 | |||
| Information Ratio | 0.1974 | |||
| Maximum Drawdown | 22.77 | |||
| Value At Risk | (1.74) | |||
| Potential Upside | 3.47 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |